Anti-seizure drug may guard against some cancers - KWWL - Eastern Iowa Breaking News, Weather, Closings

Anti-seizure drug may guard against some cancers

Updated:
© iStockphoto.com / Thinkstock © iStockphoto.com / Thinkstock
  • Health Connections - Featured Health SpecialistsHealth PartnersMore>>

  • Scott Pharmacy

    Scott Pharmacy


    Scott Pharmacy, Inc. is a privately owned and operated business that has served the residents of Fayette County for more than 30 years. We are loyal to our patients.
    More >>

    Scott Pharmacy, Inc. is a privately owned and operated business that has served the residents of Fayette County for more than 30 years. We are loyal to our patients and will ensure that your order is filled quickly and correctly.
    More >>
  • Cedar Valley Medical Specialists

    Cedar Valley Medical Specialists


    Cedar Valley Medical Specialists, P.C. represents more than 60 providers in 20+ medical fields. By working together, the professional providers of Cedar Valley Medical Specialists, P.C. have focused our delivery
    More >>
    Cedar Valley Medical Specialists, P.C. represents more than 60 providers in 20+ medical fields. By working together, the professional providers of Cedar Valley Medical Specialists, P.C. have focused our delivery of quality healthcare on you and your family.More >>

MONDAY, March 24, 2014 (HealthDay News) -- A drug used to treat seizures may reduce the risk of head and neck cancers, a new study suggests.

Valproic acid (Depakote) is prescribed to prevent seizures and also to control mood, but it is also being investigated for cancer prevention because it inhibits genetic changes that can lead to cancer.

The new study included nearly 440,000 U.S. veterans, including about 27,000 who were taking valproic acid for bipolar disorder, post-traumatic stress disorder (PTSD), migraines and seizures. Overall, veterans who took the drug for at least one year were 34 percent less likely to develop head and neck cancers than those who didn't take the drug, the investigators found.

The risk appeared to be even lower in those who took it in higher doses or for longer periods of time, according to the study published online March 24 in the journal Cancer.

Veterans who took valproic acid did not have a reduced risk for lung, bladder, colon or prostate cancers, said team leader Dr. Johann Christoph Brandes, of the Atlanta Veterans Affairs Medical Center and Emory University in Atlanta, and colleagues.

"A 34 percent risk reduction for the development of head and neck cancer with [valproic acid] use could result in the prevention of up to approximately 16,000 new cases and 3,000 to 4,000 annual deaths in the U.S. alone," Brandes said in a journal news release.

"Head and neck cancer is an important global health crisis, and low cost and low toxicity prevention strategies like [valproic acid] use have a high potential impact on pain, suffering, costs, and [death] associated with this disease," he added.

Although the study found an association between valproic acid use and reduced risk of certain cancers, it did not prove cause-and-effect.

More information

The U.S. National Cancer Institute has more about head and neck cancers.

Copyright © 2014 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KWWL. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service and Mobile Privacy Policy & Terms of Service.

Persons with disabilities who need assistance with issues relating to the content of this station's public inspection file should contact Administrative Assistant Sandy Youngblut at 319-291-1259. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, at 888-835-5322 (TTY) or at fccinfo@fcc.gov.